Columbus, OH 的 克隆氏症 臨床試驗
8 項針對 克隆氏症 的研究正在 Columbus（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- The Ohio State University /ID# 265577, Columbus
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Ohio Gastroenterology Group Inc.-8400006, Columbus
- OSU Wexner Medical Center-Site Number: 8400077, Columbus
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Ohio Gastroenterology Group Inc.-Site Number: 8400006, Columbus
- Medical Associates Research Group-Site Number: 8400063, Columbus
- OSU Wexner Medical Center-Site Number: 8400077, Columbus
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- Ohio Gastroenterology group, Inc., Columbus
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
招募中4 期
- Nationwide Children's Hospital, Columbus
Precise Infliximab Exposure and Pharmacodynamic Control
招募中2/3 期
- Nationwide Children's Hospital, Columbus
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
招募中2 期
- OSU Inflammatory Bowel Disease Center, Hilliard · 距離 10 英里
其他城市的 克隆氏症 試驗
- New York City, NY35 項研究
- Boston, MA19 項研究
- Miami, FL19 項研究
- Cleveland, OH19 項研究
- St. Louis, MO19 項研究
- Tyler, TX17 項研究
- Houston, TX17 項研究
- Orlando, FL17 項研究
- Atlanta, GA17 項研究
- San Antonio, TX15 項研究
- San Diego, CA15 項研究
- Los Angeles, CA15 項研究
Columbus 的其他研究
- 非小細胞肺癌57 項研究
- 乳癌40 項研究
- 卵巢癌39 項研究
- 癌症（所有類型）38 項研究
- 肺癌37 項研究
- 急性髓系白血病35 項研究
- 慢性淋巴性白血病28 項研究
- 轉移性癌症27 項研究
- 子宮內膜癌25 項研究
- 前列腺癌24 項研究
- 多發性骨髓瘤24 項研究
- 大腸直腸癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。